Summary There is ample evidence of the efficacy of cytological screening in the prevention of cervical cancer but disagreement on the form which screening programmes should take. Simulation models have been used as a convenient and rapid method of exploring the outcome of different screening policies and of demonstrating the importance and interrelationships of the variables concerned. However, most such models are either too abstract or too simplistic to be of practical value in planning screening programmes.
Summary There is ample evidence of the efficacy of cytological screening in the prevention of cervical cancer but disagreement on the form which screening programmes should take. Simulation models have been used as a convenient and rapid method of exploring the outcome of different screening policies and of demonstrating the importance and interrelationships of the variables concerned. However, most such models are either too abstract or too simplistic to be of practical value in planning screening programmes.
A model is described which reproduces demographic events in a female population (that of England and Wales) over a 30 year period, and onto this superimposes the natural history of cervical carcinoma, using data derived from published studies. A microsimulation approach -each individual in the population being retained as a unit -allows factors such as disease onset and screening uptake to be dependent upon personal characteristics and past events. Screening can be offered as part of a routine programme, or incidentally -for example during pregnancy or hospital attendance.
The model allows quantitative evaluation of the complex patterns of screening that are actually observed and the relative importance of the different components of such screening programmes. Assumptions about natural history can thus be studied.
Cervical cytology screening is an effective means of reducing the incidence of invasive cancer of the cervix (Guzick, 1978; . However, the decision to introduce a screening programme into a population will depend upon considerations of the degree of benefit obtainable in relation to the resources deployed and this ratio will vary considerably with the actual programme design (who is to be examined, where, and how often). The utility of randomised trials to evaluate complex programmes involving repeated examinations and follow-up of large numbers of subjects is limited by the time and expense involved. It is possible to investigate only a limited number of screening schedules and the methodology used may be deemed obsolete or inappropriate by the time results become available. Finally, the apparently obvious benefit to be gained from early diagnosis means that it is difficult to convince physicians and their patients of the need for a controlled trial, so that they may be judged unethical, or the control group receive screening outside the trial.
Health care models are a convenient way of predicting the results of different interventions, given varying assumptions about the relationships involved. Their advantages have been summarised by Eddy & Schwartz (1982) . Simulation models aim to mimic observed processes as closely as possible, in the hope that the resulting predictions will be a guide to future results. Although the assumptions used and processes modelled have to be stated explicitly and quantitatively, the availability of computers means that there is no imperative reason to seek concise mathematical solutions. The Coppleson & Brown (1975) is the simplest, a Markov process using just 4 states (normal, dysplasia, carcinoma in situ (c.i.s.) and invasive cancer) and a set of transition rates between them compatible with observed cross-sectional data on incidence and prevalence of the preclinical states (Bibbo et al., 1971) , and cumulative incidence of clinical cancer (Cutler & Young, 1975) . A timeinvariant model using single rates of transition between states was unable to simulate the observed data and the solution adopted was to allow each of the transition rates to vary with age. However, although the observational data could be used to estimate certain transition rates (normal to dysplasia, c.i.s. to cancer), other choices were more or less arbitrary and a variety of combinations were capable of reproducing the observed prevalences.
The earliest and most comprehensive simulation model was that of Knox (1973) Ltd., 1985 transitions between them in a cohort of 10,000 women as they age from 16 to 95. The model is rather more sophisticated than that of Coppleson and Brown since it allows transitions between states to be defined in terms of age or by duration in initial state. The choice of transition rates to use is again determined by the need to simulate observed age-specific prevalence data, and incidence and mortality of clinical cancer, but within these constraints the actual rates chosen appear to be rather arbitrary. Screening is simulated by defining the ages at which examinations are to be "offered" during the 95 year lifespan of the cohort and the percentage attendance (acceptance rate). The model addresses differential uptake of screening programmes by making acceptance dependent on state (reasoning that the risk factors for cervical cancer, and its precursor conditions, are the same as those that determine acceptance of screening). Test characteristics are simulated by specifying the percentage of the population in the diseased and normal states who will be deemed positive on screening.
An identical approach using the same model has recently been published by a Canadian group (Yu et al., 1982) . They chose to use a rather simplified natural history, ignoring the existence of abnormalities preceding in situ cancer; incidence of the latter was derived by tripling the rates observed in British Columbia (Boyes et al., 1982) , and by assuming a zero incidence after age 55.
Such models which transfer year by year specified proportions of a single cohort in a deterministic fashion have been very useful in demonstrating the interrelationships between variables, e.g. between the number of tests offered per lifetime of a cohort member and the total tests performed, mortality rate and person-years of life saved in the entire cohort. The effects of different acceptance rates and test characteristics on these outcome measures can be explored. The net costeffectiveness of different theoretical screening policies can be examined by imputing costs to the different outcomes of screening tests (Blumberg, 1957 (Hakama, 1982; , and which mean that it may be necessary to change the policy (e.g. ages for screening) at different time&periods.
Secondly, it may be desirable to use characteristics other than age to identify subgroups of the population for "selective screening". Such policies do not have to be "all or nothing" -indeed, none of the risk factors which could reasonably be used have a high enough relative risk to justify screening only a single group (Hakama et al., 1979) , but they could include more frequent screening of certain subgroups. Several demographic variables are associated with increased disease risk: social class/occupation (Beral, 1974) , marital status (Leck et al., 1978) , parity (Miller et al., 1980) . The prevalence and incidence of precursor lesions are also related to these variables (Sweetnam et al., 1981; Parkin et al., 1982b) . None of these are directly causative, they are all related to the underlying confounding variable of sexual activity. However, from the practical viewpoint this is of little consequence, provided that the relevant subgroups are easily identifiable, and a planning model should be able to explore the effectiveness of policies involving differential screening of such subpopulations.
Individual factors also influence attendance at screening programmes; e.g., age, marital status and social class, (Sansom et al., 1971; Parkin et al., 1981) . Several studies suggest that non-attenders are a particularly high risk group, having incidence rates higher than those expected on the basis of pre-screening rates (Fidler et al., 1968; Hakama & Rasanen-Virtanen, 1976) . Attendance in future is often related to past screening history.
Finally, in real life, screening programmes do not exist in isolation from the rest of the health care system; the majority of smears are taken "incidentally", that is at the time of contacts with health services for other purposes -gynaecology clinics, family planning services, ante-natal attendances (Parkin et al., 1981; Roberts, 1982) . When screening policies are under consideration such testing is usually ignored as being "diagnostic" rather than true screening. Gynaecological symptoms, in particular, are strong predictors of the existence of dysplasia and carcinoma in situ (Thomas, 1973; Cooper & Hillier, 1975; Parkin et al., 1982a) , so that the testing of women at hospital clinics can be considered a form of selective screening; such subjects are likely to be at high risk of these conditions by virtue of common aetiological factors with other gynaecological or venereal diseases. Attenders of family planning services will also be at higher than average risk by being, by definition, a sexually active population; in addition, oral contraceptives possibly constitute an independent risk factor (Vessey et al., 1983) . Smears taken on such occasions represent marginal increments to services being delivered for other purposes and will have lower costs than those delivered in special screening clinics. The same is true for testing in relation to pregnancy. A planning model should take account of all relevant screening activity, rather than confining itself to evaluating unrealistic theoretical policies defined only in terms of age and interval.
It was the need to develop a practical planning tool which lead to the development of model systems able address some of the issues described.
Model structure A simple single cohort deterministic model based on the programme written by Knox (1973) The main model uses a different approach. Because of the need to make natural history and screening variables dependent upon characteristics of individuals (such as age, year of birth, marital status, past history), a microsimulation approach has been used, where the life histories of individual members of the population are modelled. The population used is of arbitrary size, but has the demographic makeup of that of England and Wales, and events are studied over a 30 year period . Each individual in the population is characterised by their values for a set of variables which will be used in ,Qimulating demographic events, disease natural history or screening programmes. In practice a minimum of 7 variables has been used ( Table I) .
The values of these variables for each individual are updated annually. The data-files for the model consist of sets of conditional probabilities of transition for each of these variable values, e.g. the probability of childbirth (change in value of parity variable) given age, marital Alderson & Donnan (1978) and by extrapolating rates backwards in time they estimated age-specific prevalence of hysterectomy at different dates. Their estimates of prevalence for 1961 are used in the "Assignment" procedure.
Simulation of the disease process
The disease process is simulated by defining a series of mutually exclusive "states", and the natural history consists of transfers between these states at rates dependent upon individual characteristics. The states must include normal, dead (of causes other than cancer) and hysterectomy, but otherwise the choice is arbitrary. Clearly, however, the simpler and closer to reality the formulation used, the less difficult it is to use observational data to derive transition rates. Figure 2 illustrates the set of states used in the examples to be described, and the possible transitions between them.
The "Assignment" procedure ( Figure 1 ) requires that the individuals in the starting population are allocated to the disease states according to their age, marital state and parity. Estimates of the age-specific prevalence of dysplasia, carcinoma in situ (c.i.s.) and preclinical invasive disease in unscreened populations are available from several studies (Dunn & Martin, 1967; Bibbo et al., 1971; Fidler et al., 1968; Sweetnam et al., 1981; Parkin et al., 1982b) . Prevalence of clinical cancer (women currently alive who have had a previous diagnosis of clinical cancer) must be estimated from incidence of clinical cancer prescreening, and survival rates for the same time period. Appendix A shows a set of estimated age-specific prevalences of the pre-clinical states, clinical cancer, and also of hysterectomy. The variation of prevalence of preinvasive disease by parity and marital state can be estimated from published data (Sweetnam et al., 1981; Parkin et al., 1982a) .
During the simulation, disease natural history is modelled in the "Transfer" procedure by the stochastic transfer of individuals between states according to probabilities conditional upon age, duration in state, marital status and parity. Three sets of transition rates corresponding to different natural histories (HI, H2 and H3) are reproduced in Appendix B. Figure 3 illustrates the distribution of sojourn times of pre-invasive states with these three different natural histories. The total number of c.i.s. which progress to invasion (proportional to the shaded area under the lower curves) is the same in all three, but the distributions are exponential in HI and H2, and peaked in H3. With HI, the proportion of c.i.s. which regress is much lower than with the other two natural histories. In all three, however, dysplasia is a relatively transient condition; the majority regress, and the median duration is only 2-3 years.
Simulation of screening andfollow-up There is considerable flexibility in modelling screening programmes. The "Screening" procedure ( Figure 1 ) is used to specify policies of "routine" screening, which are defined by:
1. The years of the simulation routine in which screening is to be offered. (Roberts, 1982) corresponds very closely to the numbers of gynaecology admissions. For simplicity, therefore, the model approximates gynaecological testing by using agespecific in-patient admission rates derived from HIPE for 1966-80 with extrapolations beyond these years based on an observed annual increase of 2%. For individuals with pre-clinical lesions (states 2-4) attendance rates are multiplied by 3 to correspond with the observed relative prevalence (first smears only) of abnormalities in clinic attenders compared to other sources of tests (Parkin et al., 1982a) . There is much less information about rates of attendance for family planning services, although about 1.5 million women attend community clinics each year (Roberts, 1982 (Figure 4 ). It is possible to devise sets of transition rates between disease states which differ for successive time periods in order to mimic the cohort changes in disease incidence that seem to be occuring in England and Wales. In the examples below, the same set of data have been used for the entire period ; however, when transition from normal to dysplasia is made dependent upon marital state and parity, the changing pattern of marriage and divorce and, to a much lesser extent, childbearing will result in changing disease rates. Figure 5 shows the progressive rise in the prevalence of dysplasia and carcinoma in situ during the period of simulation. At the beginning of simulation the age-specific incidence curve of clinical cancer is close to that observed, as it should be, since the observed incidence was used in the derivation of natural history. However, in the absence of screening, predicted incidence and mortality both show a steady rise throughout the 30 years of simulation when transition rates conditional upon age, marital state and parity are used ( Figure 6 , curve M), but not when these rates are related only to age (curve A). In reality a decline in incidence and mortality is being seen in England and Wales, although this is almost certainly as a result of the screening programmes, without which both would have risen . Figure 7 Cumulative person-years of life lost during the 30-year simulation period. The upper diagram presents the results using natural history H1, the lower using H3. The upper curve shows the potential lifeyears lost each year in the absence of screening, the lower curve is the loss when the population aged 35-65 is screened at 5-year intervals, with an 80% attendance rate (Policy A, Table II). schedule of 5-yearly screenings, there will always be a proportion of clinical cancers which pass through their pre-invasive stages in less than 5 years. This relationship is complicated by a less than perfect detection of abnormalities on screening (70% sensitivity) and the escape of a small proportion of screen-detected cases from surveillance. In this simple example, the number of screening tests carried out in the population is directly proportional to the attendance rate, so that the ratio of savings to tests also falls with increasing attendance rates. However, this decline is less steep for the ratio "savings per positive test", because the yield of screening (proportion of tests which are positive) falls as the intensity of screening increases (from 20 per 1000 at 15% attendance to 16.3 per 1000 at 90% attendance). This is a consequence of a reduction in prevalence of preclinical lesions in the population with an increased intensity of screening.
The micro-simulation model allows screening attendance to be made conditional upon personal variables, some examples are shown in Table III . A simplistic situation is illustrated by columns 4 and 5, where, within an overall attendance rate of 60%, the outcome of screening when the probability of attendance is the same for all individuals ("random") is compared to that when 20% of women never attend. The savings when there is a group of non-attenders are inferior to those Table II ). AttendanceRandom, from 0%-90%. (0) In the same table, the effect of making probability of attendance depend upon marital state is shown. The ratios chosen are 5:9:2 for single: married: formerly married (the approximate ratio observed in the Leeds-Wakefield study of Parkin et al., 1981 Examinations at ages 35, 40, 45, 50, 55, 60, 65 As shown in Table  Sensitivity Table IV examines two other possibilities which envisage more successful surveillance. As quality of follow-up deteriorates so do the savings achieved (cases, lives, life-years), and there is a small increase in the number of tests carried out (fewer people are successfully treated or under permanent surveillance) and in the proportion of screening tests that are positive (since the prevalence of precursor lesions which are not treated or under follow-up will increase). Nevertheless, within the range examined here the differences in savings achieved and in the ratio of savings to tests are rather small. Screening test performance is defined in terms of sensitivity and specificity, and these bear a reciprocal relationship to each other. In the programmes so far examined a test sensitivity of 70% and specificity of (Husain, 1976; Boyes et al., 1982) . In Table IV Since dysplasia is assumed to be a rather transient lesion, the great majority of which regress to normality, the effect of ignoring screening tests showing minor degrees of abnormality (consistent with dysplasia) has been examined. There is a large reduction in positive tests; however, failure to follow-up dysplasias leads to a reduction in the savings achieved, so that although the ratios of savings per positive test are improved, the ratios of savings per 1000 tests are worse. Whether such a policy is worthwhile depends on the relative costs imputed to negative tests and to true and false positives and a comparison with the benefits obtained.
Columns 4-6 of Table V examine the effects of "incidental" testing. Pregnancy-related screening (e.g. Outcome 1961 Outcome -1990 As shown in the (Habbema et al., 1979) . However, in order to surmount the problems of the deterministic model, they have subsequently developed a microsimulation model (Oortmarssen et al., 1981; Habbema et al., 1983 The natural history of preclinical carcinoma of the cervix is a continuum: the extension of cellular abnormalities to involve the entire thickness of the cervical epithelium and subsequent invasion, and progressively increasing cellular atypia. When this is simulated by a set of discrete "states", it seems unlikely that rates of transfer between them are independent of the duration already spent in a state (the fundamental property of a Markov process). Such independence would imply that the distribution of sojourn times of the disease stages was exponential in form. There is no evidence for or against this, but it seems prudent to allow for other possibilities. It was not possible to devise a natural history compatible with observed prevalence of preclinical states and incidence of invasive cancer in which transfer probabilities were independent of age; in the three versions used the probability of progression to invasive disease increases in older women. A variation in the speed of evolution of pre-clinical carcinoma of the cervix with age has been proposed from time to time (Lancet, 1981) , and although the biological mechanism underlying this must be speculative, it could conceivably be due to differences in the proportions of dysplastic lesions related to viral infection (Singer et al., 1984) .
The choice of disease states in a model should correspond to categories familiar in clinical or pathological studies (so that observed data are available for use in the model), and also be the minimum possible, so that the specification of disease natural history is simplified. There has been a recent trend to the use of the terminology "cervical intra-epithelial neoplasia" (C.I.N.) for all pre-invasive abnormalities of the cervix (Richart & Barron, 1969; Koss, 1978 (Rotkin, 1973) or their partner (Skegg et al., 1982) The incidence of dysplasia (transfer 1 to 2) is derived from observed data (Dunn & Martin, 1967; Parkin et al., 1982b) , and transition from clinical cancer to death (5 to 8) is derived from age/duration-specific survival rates for England and Wales (OPCS, 1980) . Dysplasia is a relatively transient condition, and the high regression rates (2 to 1) used here (12.5-25% per year) are consistent with observed data (Stern & Neely, 1964; Fox, 1967; Nasiell et al., 1976) . In HI c.i.s. (state 3) is made a relatively stable condition by specifying low rates of entry from (2 to 3) and regression to (3 to 2) dysplasia; these are considerably higher in H2 and H3. In HI and H2 transition from c.i.s. to preclinical invasive disease (3 to 4) is age-dependent only, and calculated from age-specific prevalence of c.i.s. and incidence of clinical cancer in the absence of screening. Transition rates in H3 are the same as those in H2, except that progression from c.i.s. is dependent upon duration. The rate/duration pairs are arbitrary inasmuch as they are derived so that the observed prevalence of c.i.s. and incidence of clinical cancer are reproduced by the model; in practice, this imposes considerable constraints on the range of values that can be used.
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